{"organizations": [], "uuid": "0028fdce6b7efbe859d4e6a8bfda828fb7a6fc0c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/02/15/the-associated-press-cytokinetics-reports-4q-loss.html", "country": "US", "domain_rank": 767, "title": "Cytokinetics reports 4Q loss", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T23:34:00.000+02:00", "replies_count": 0, "uuid": "0028fdce6b7efbe859d4e6a8bfda828fb7a6fc0c"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/02/15/the-associated-press-cytokinetics-reports-4q-loss.html", "ord_in_thread": 0, "title": "Cytokinetics reports 4Q loss", "locations": [], "entities": {"persons": [], "locations": [{"name": "san francisco", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "south san francisco", "sentiment": "none"}], "organizations": [{"name": "cytokinetics inc.", "sentiment": "negative"}, {"name": "cytokinetics", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SOUTH SAN FRANCISCO, Calif. (AP) _ Cytokinetics Inc. (CYTK) on Thursday reported a fourth-quarter loss of $40.5 million, after reporting a profit in the same period a year earlier.\nOn a per-share basis, the South San Francisco, California-based company said it had a loss of 75 cents.\nThe results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 71 cents per share.\nFor the year, the company reported a loss of $127.8 million, or $2.59 per share, swinging to a loss in the period. Revenue was reported as $13.4 million.\nCytokinetics shares have increased roughly 5 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.55, a drop of 25 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK", "external_links": [], "published": "2018-02-15T23:34:00.000+02:00", "crawled": "2018-02-15T23:57:18.001+02:00", "highlightTitle": ""}